Mr. Paul J. Donnelly

• 
  medicalfutures.co.uk/i2event_innerpage.php?category=Fac - [Cached Version]
  Published on: 7/27/2008    Last Visited: 7/27/2008  

  Paul Donnelly
  
  Managing Director and President, Sterilox Technologies International
  
  Paul is a serial entrepreneur with over 20 years experience in the medical devices sector and recently floated PuriCore, which has a market capitalisation of £120m.

• 
  www.puricore.com/about_leadership.aspx - [Cached Version]
  Published on: 6/2/2008    Last Visited: 6/2/2008  

  Paul J. DonnellyManaging Director and President, PuriCore InternationalMr. Donnelly joined PuriCore in January 2004 as the Managing Director of Sterilox U.K. operations.Mr. Donnelly started his career in sales and marketing for Johnson and Johnson and led the Northern European Orthopedic implant business.Mr. Donnelly was the CEO of the Cremascoli Orthopedic group and led its successful sale to Wright Medical.He was the Global Marketing Director for Verigen AG, the Candover-owned German technology firm, which was later sold to Genzyme.Prior to joining PuriCore, he was the European Managing Director for SSL International PLC's medical group and was a management team member who led the successful sale of this division to APAX partners in 2004.He held a number of senior international business development and operational roles with CR Bard as well as GlaxoSmithKline.Mr. Donnelly holds a BA Hons in Marketing from the University of Strathclyde.

• 
  www.puricore.com/about_leadership_executive.aspx - [Cached Version]
  Published on: 3/16/2007    Last Visited: 3/16/2007  

  Paul J. Donnelly, Managing Director and President, PuriCore InternationalMr. Donnelly joined PuriCore in January 2004 as the Managing Director of Sterilox U.K. operations.Mr. Donnelly started his career in sales and marketing for Johnson and Johnson and led the Northern European Orthopedic implant business.Mr. Donnelly was the CEO of the Cremascoli Orthopedic group and led its successful sale to Wright Medical.He was the Global Marketing Director for Verigen AG, the Candover-owned German technology firm, which was later sold to Genzyme.Prior to joining PuriCore, he was the European Managing Director for SSL International PLC's medical group and was a management team member who led the successful sale of this division to APAX partners in 2004.He held a number of senior international business development and operational roles with CR Bard as well as GlaxoSmithKline.Mr. Donnelly holds a BA Hons in Marketing from the University of Strathclyde.

• 
  www.medicalfutures.co.uk/faculty2.php?category=Faculty& - [Cached Version]
  Published on: 1/23/2007    Last Visited: 7/27/2008  

  Paul Donnelly
  ...
  Paul started his career in sales and marketing for Johnson and Johnson and led the Northern European Orthopedic implant business.He then became the CEO of the Cremascoli Orthopedic group and led its successful sale to Wright Medical.He was the Global Marketing Director for Verigen AG, the Candover-owned German technology firm, which was later sold to Genzyme.He was the European Managing Director for SSL International PLC's medical group and was a management team member who led the successful sale of this division to APAX partners in 2004.He held a number of senior international business development and operational roles with CR Bard as well as GlaxoSmithKline.Mr. Donnelly holds a BA Hons in Marketing from the University of Strathclyde and is a founding member of the Strathclyde 100.
  
  In 2004 he became the Managing Director of Sterilox U.K. operations, part of PuriCore and was instrumental in the company's recent flotation on the London Stock Market with a market capitalisation of £120m.

• 
  www.tani.org.uk/ - [Cached Version]
  Published on: 6/30/2006    Last Visited: 10/8/2007  

  TANI would like to express its gratitude to Mr Paul Donnelly who retired from his role as TANI Child Protection Officer.

• 
  AP Wire | 01/30/2004 | Pennsylvania business news in... - [Cached Version]
  Published on: 1/30/2004    Last Visited: 1/30/2004  

  RADNOR, Pa. (AP) - Sterilox Technologies Inc., a suburban Philadelphia company that manufactures non-toxic disinfectants, named Paul J. Donnelly to a newly created executive position.
  
  Donnelly will become managing director and president of the international division, based at the company's United Kingdom headquarters in Stoke-on-Trent, England.
  
  Donnelly, who has more than 20 years experience in the medical devices sector, is charged with expanding the company's international business and broadening its portfolio from its endoscopy focus, to medical and non-medical disinfection and decontamination applications.
  
  Prior to joining Sterilox, Donnelly was the European managing director of SSL's medical division and held various senior jobs at Johnson & Johnson and CR Bard.

• 
  Accolades for the healthcare industry: News from Frost... - [Cached Version]
  Published on: 9/23/2005    Last Visited: 10/21/2005  

  The distinguished panellists included Arni Alvar Arason, vice president sales and marketing, Ossur, Luc Vandenbroucke (senior vice president Barco, president BarcoView), Paul Donnelly (managing director and president, Sterilox Technologies International), and Bernd Ohnesorge.

• 
  Accolades to the Healthcare Industry: Frost & Sullivan... - [Cached Version]
  Published on: 9/22/2005    Last Visited: 9/22/2005  

  The distinguished panellists included Mr. Arni Alvar Arason, Vice President Sales & Marketing, Ossur), Mr. Luc Vandenbroucke (Senior Vice President Barco, President BarcoView), Mr. Paul Donnelly (Managing Director & President, Sterilox Technologies International Ltd.), and Dr. Bernd Ohnesorge.

• 
  Autologistics Global - Industry feedback I - [Cached Version]
  Published on: 7/25/2004    Last Visited: 5/9/2005  

  Paul Donnelly, Marketing Director,

• 
  DRAFT:1 - [Cached Version]
  Published on: 1/30/2004    Last Visited: 4/29/2006  

  RADNOR, PA, January 30, 2004 -- Sterilox Technologies Inc., the world's leading manufacturer of non-toxic disinfectants, today announced the appointment of Paul J. Donnelly to the newly created position of Managing Director and President, International.
  
  Donnelly has over 20 years experience in the medical devices sector, as well as a 14-year track record of building and managing successful international businesses.His role is to accelerate the expansion of the company's international business (outside North America) and broaden its portfolio from its current endoscopy focus, to medical and non-medical disinfection and decontamination applications.
  ...
  "Paul will be the catalyst to lead a successful U.K. operation into an international organization which will extend infection control technologies and expertise beyond traditional applications."
  
  Based at the company's U.K. headquarters in Stoke-on-Trent, Donnelly will also work closely with the U.K. team to ensure that Sterilox consolidates and builds on its substantial share of the national endoscopy disinfectant market.Sterilox is currently one of the largest providers of sterilants to endoscopy suites in the U.K. National Health Service Trust hospitals.
  
  Prior to joining Sterilox, Donnelly was the European Managing Director of SSL's Medical Division, was appointed to accelerate the commercialization of Verigen AG's proprietary cartilage technology, and held a number of senior international business development and operational roles with Johnson & Johnson, as well as CR Bard.

Page:  1 2